FDA interim commissioner-designate is Michael Friedman; Kessler to depart in Feb..
This article was originally published in The Rose Sheet
Executive Summary
FDA INTERIM COMMISSIONER-DESIGNATE FRIEDMAN will take over leadership of the agency following the upcoming departure of Commissioner David Kessler, MD, in February. FDA announced Jan. 30 that Deputy Commissioner for Operations Michael Friedman, MD, will take the reins of the agency on an acting basis. Kessler, who announced his resignation in November, has been offered the position of Dean at Yale Medical School ("The Rose Sheet" Jan. 27, In Brief).